Multimodal Molecular Analysis Reveals Divergent Trajectories of Wound Regeneration Versus Fibrosis

    Heather E. desJardins-Park, Shamik Mascharak, Michael Januszyk, Kellen Chen, Michael F. Davitt, János Demeter, Dominic Henn, Michelle Griffin, Clark A. Bonham, Nancie A. Mooney, Ran Cheng, Peter K. Jackson, Derrick C. Wan, Geoffrey C. Gurtner, Michael T. Longaker
    From the encyclopedia
    Verteporfin →

    chemical that might completely regrow follicles from hair transplant extractions

    Studysummary This study found that treating wounds in mice with the drug verteporfin, which inhibits mechanical signaling, leads to skin regeneration associated with the activation of Wnt pathway proteins. Our plain-language summary of this paper — not a Tressless recommendation.
    The study "Multimodal Molecular Analysis Reveals Divergent Trajectories Of Wound Regeneration Versus Fibrosis" investigated the molecular events distinguishing typical scarring healing from wound regeneration induced by the drug verteporfin. The research involved C57BL/6J mice, with wounds treated with either verteporfin or a control, and samples taken at various timepoints (2, 7, 14, and 30 days post-operation). The study found that fibroblasts, a type of cell that synthesizes the extracellular matrix and collagen, followed two distinct transcriptional trajectories. One was characterized by mechanical activation and led to fibrosis (scarring), while the other was characterized by developmental and regenerative pathways leading to wound regeneration. The regenerative pathway was associated with suppression of mechanical signaling and activation of key Wnt pathway members, including Trps1, a gene with known hair follicle developmental roles. This suggests that inhibiting mechanical signaling could unlock wound regeneration and potentially offer new anti-scarring therapeutic avenues.
    Discuss this study in the Community →